Immunic (IMUX) Enterprise Value (2013 - 2026)
Immunic (IMUX) posted Enterprise Value of -$186.6 million for Q1 2026, down 1105.19% sequentially from -$15.5 million in Q4 2025, and down 1204.53% YoY from $16.9 million in Q1 2025.
Immunic (IMUX) Enterprise Value (2013 - 2026) Analysis & Trends
Immunic has reported Enterprise Value for 14 years, with the latest figure at -$186.6 million in Q1 2026.
- Quarterly Enterprise Value fell 1204.53% year-over-year to -$186.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$186.6 million (down 1204.53% YoY) and the FY2025 annual result came in at -$15.5 million, up 56.59% from the prior year.
- Enterprise Value fell to -$186.6 million in Q1 2026 per IMUX's latest filing, from -$15.5 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$14.3 million in Q1 2025 and troughed at -$186.6 million in Q1 2026.
- A 5-year average of -$72.5 million and a median of -$72.8 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value jumped 85.3% in 2025, then slumped 1204.53% in 2026.
- Over 5 years, Enterprise Value stood at -$116.4 million in 2022, then jumped by 59.89% to -$46.7 million in 2023, then gained by 23.58% to -$35.7 million in 2024, then soared by 56.59% to -$15.5 million in 2025, then slumped by 1105.19% to -$186.6 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$186.6 million, -$15.5 million, and -$35.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | -155.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -155.10 Mn |
| Mar 31, 2026 | -186.60 Mn |
| Dec 31, 2025 | -15.48 Mn |
| Sep 30, 2025 | -35.13 Mn |
| Jun 30, 2025 | -55.31 Mn |
| Mar 31, 2025 | -14.30 Mn |
| Dec 31, 2024 | -35.67 Mn |
| Sep 30, 2024 | -59.07 Mn |
| Jun 30, 2024 | -79.70 Mn |
| Mar 31, 2024 | -97.31 Mn |
| Dec 31, 2023 | -46.67 Mn |
| Sep 30, 2023 | -59.70 Mn |
| Jun 30, 2023 | -77.30 Mn |
| Mar 31, 2023 | -97.11 Mn |
| Dec 31, 2022 | -116.37 Mn |
| Sep 30, 2022 | -72.77 Mn |
| Jun 30, 2022 | -88.10 Mn |
| Mar 31, 2022 | -95.70 Mn |
| Dec 31, 2021 | -86.86 Mn |
| Sep 30, 2021 | -110.44 Mn |